ET
OLMA icon

Entropy Technologies’s Olema Pharmaceuticals OLMA Stock Holding History

Entropy Technologies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$235K Sell
15,773
-1,531
-9% -$34.1K 0.01% 760
2025
Q4 		$433K Buy
+17,304
New +$308K 0.02% 597
2024
Q2 		– Sell
-14,246
Closed -$161K – 864
2024
Q1 		$161K Buy
+14,246
New +$184K 0.02% 667

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Entropy Technologies's OLMA Position: Q1 2026 in Review

Entropy Technologies reduced its Olema Pharmaceuticals (OLMA) stake by 8.8% in Q1 2026, selling an estimated $34.1K and leaving 15,773 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #760.

Entropy Technologies first reported a position in OLMA in Q1 2024 and has held it in 3 quarters since. The position peaked at $433K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Entropy Technologies held 15,773 shares of Olema Pharmaceuticals worth $235K as of Q1 2026.
  • Entropy Technologies sold 1,531 Olema Pharmaceuticals shares in Q1 2026, an estimated $34.1K.
  • Olema Pharmaceuticals made up 0.01% of Entropy Technologies's portfolio in Q1 2026, its #760 holding.
  • Entropy Technologies first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • Entropy Technologies's Olema Pharmaceuticals position peaked at $433K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.